| Ident. | Authors (with country if any) | Title |
|---|
| 000003 |
Stéphanie Bissonnette [Canada] ; Sophie Muratot [Canada] ; Nathalie Vernoux [Canada] ; François Bezeau [Canada] ; Frédéric Calon [Canada] ; Sébastien S. Hebert [Canada] ; Pershia Samadi [Canada] | The effect of striatal pre-enkephalin overexpression in the basal ganglia of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease |
| 000035 |
Anna Effenberg [Allemagne] ; Alexander Klein [Allemagne] ; Robbin Gibb [Canada] ; Cathy Carroll [Canada] ; Wolfgang Baumgartner [Allemagne] ; Claudia Grothea [Allemagne] ; Andreas Ratzka [Allemagne] | Adult hemiparkinsonian rats do not benefit from tactile stimulation |
| 000071 |
Philip Seeman [Canada] ; Michele Tinazzi [Italie] | Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia |
| 000165 |
Anne Almey [Canada] ; Edward J. Filardo [États-Unis] ; Teresa A. Milner [États-Unis] ; Wayne G. Brake [Canada] | Estrogen Receptors Are Found in Glia and at Extranuclear Neuronal Sites in the Dorsal Striatum of Female Rats: Evidence for Cholinergic But Not Dopaminergic Colocalization |
| 000175 |
S. Al-Sweidi [Canada] ; M. Morissette [Canada] ; T. Di Paolo [Canada] | Effect of Oestrogen Receptors on Brain NMDA Receptors of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mice |
| 000245 |
T. Wichmann [États-Unis] ; J. O. Dostrovsky [Canada] | PATHOLOGICAL BASAL GANGLIA ACTIVITY IN MOVEMENT DISORDERS |
| 000271 |
Anne M. Landau [Danemark, Canada] ; M. Mallar Chakravarty [Danemark, Canada] ; Campbell M. Clark [Canada] ; Athanasios P. Zis [Canada] ; Doris J. Doudet [Danemark, Canada] | Electroconvulsive Therapy Alters Dopamine Signaling in the Striatum of Non-human Primates |
| 000308 |
Marc Morissette [Canada] ; Pershia Samadi [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Nancy Belanger [Canada] ; Thérèse Di Paolo [Canada] | Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys |
| 000322 |
Pierre-Luc Tremblay [Canada] ; Marc-Andre Bedard [Canada] ; Dominic Langlois [Canada] ; Pierre J. Blanchet [Canada] ; Martin Lemay [Canada] ; Maxime Parent [Canada] | Movement chunking during sequence learning is a dopamine-dependant process: a study conducted in Parkinson's disease |
| 000404 |
Desirae M. Haluk [Canada] ; Stan B. Floresco [Canada] | Ventral Striatal Dopamine Modulation of Different Forms of Behavioral Flexibility |
| 000466 |
JING JI [États-Unis] ; Mélanie Bourque [Canada] ; Thérèse Di Paolo [Canada] ; Dean E. Dluzen [États-Unis] | Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems |
| 000473 |
R. J. Grant [Canada] ; L. H. L. Sellings [Canada] ; S. J. Crocker [États-Unis] ; E. Melloni [Italie] ; D. S. Park [Canada] ; P. B. S. Clarke [Canada] | EFFECTS OF CALPAIN INHIBITION ON DOPAMINERGIC MARKERS AND MOTOR FUNCTION FOLLOWING INTRASTRIATAL 6-HYDROXYDOPAMINE ADMINISTRATION IN RATS |
| 000481 |
Claire Gibrat [Canada] ; Martine Saint-Pierre [Canada] ; Mélanie Bousquet [Canada] ; Daniel Levesque [Canada] ; Claude Rouillard [Canada] ; Francesca Cicchetti [Canada] | Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and α-synuclein inclusions |
| 000491 |
Dirk W. Luchtman [Canada] ; DI SHAO [Canada] ; CAI SONG [Canada] | Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease |
| 000514 |
Anthony P. Nicholas [États-Unis] ; Farah D. Lubin [États-Unis] ; Penelope J. Hallett [États-Unis] ; Padmapriya Vattem [États-Unis] ; Paula Ravenscroft [Royaume-Uni] ; Erwan Bezard [France] ; SHAOBO ZHOU [Royaume-Uni] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] ; J. David Sweatt [États-Unis] ; David G. Standaert [États-Unis] | Striatal histone modifications in models of levodopa-induced dyskinesia |
| 000517 |
F. Paquet [Canada] ; M. A. Bedard [Canada] ; M. Levesque [Canada] ; P. L. Tremblay [Canada] ; M. Lemay [Canada] ; P. J. Blanchet [Canada] ; P. Scherzer [Canada] ; S. Chouinard [Canada] ; J. Filion [Canada] | Sensorimotor adaptation in Parkinson's disease : evidence for a dopamine dependent remapping disturbance |
| 000576 |
S. Potvin [Canada] ; S. Grignon [Canada] | Dopamine et douleur : une revue de littérature : Fibromyalgie |
| 000594 |
Mélanie Bourque [Canada] ; BIN LIU [États-Unis] ; Dean E. Dluzen [États-Unis] ; Therese Di Paolo [Canada] | Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity |
| 000595 |
Brian N. Mathur [États-Unis] ; M. Diana Neely [États-Unis] ; Melanie Dyllick-Brenzinger [Canada] ; Anurag Tandon [Canada] ; Ariel Y. Deutch [États-Unis] | Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration |
| 000596 |
Brian N. Mathur [États-Unis] ; M. Diana Neely [États-Unis] ; Melanie Dyllick-Brenzinger [Canada] ; Anurag Tandon [Canada] ; Ariel Y. Deutch [États-Unis] | Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration |
| 000623 |
Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Lennard P. Niles [Canada] | Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease |
| 000647 |
Ivan L. Cepeda [Canada] ; Joseph Flores [Canada] ; Michael L. Cornfeldt [États-Unis] ; John R. O'Kusky [Canada] ; Doris J. Doudet [Canada] | Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of parkinson disease |
| 000651 |
Elissa M. Strome [Canada] ; Athanasios P. Zis [Canada] ; Doris J. Doudet [Canada] | Electroconvulsive shock enhances striatal dopamine D1 and D3 receptor binding and improves motor performance in 6-OHDA-lesioned rats |
| 000652 |
Laura Monetta [Canada] ; Marc D. Pell [Canada] | Effects of verbal working memory deficits on metaphor comprehension in patients with Parkinson's disease |
| 000654 |
Philippe Huot [Canada] ; André Parent [Canada] | Dopaminergic neurons intrinsic to the striatum |
| 000694 |
Pepijn Van Den Munckhof [Canada] ; Francois Gilbert [Canada] ; Michel Chamberland [Canada] ; Daniel Levesque [Canada] ; Jacques Drouin [Canada] | Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of parkinson's disease |
| 000709 |
Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Catherine C. Tenn [Canada] ; Lennard P. Niles [Canada] | Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease |
| 000747 |
Maryka Quik [États-Unis] ; Neeraja Parameswaran [États-Unis] ; Sarah E. Mccallum [États-Unis] ; Tanuja Bordia [États-Unis] ; SHANSHAN BAO [États-Unis] ; Alison Mccormack [États-Unis] ; Amy Kim [États-Unis] ; Rachel F. Tyndale [Canada] ; J. William Langston [États-Unis] ; Donato A. Di Monte [États-Unis] | Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates |
| 000913 |
Antonio P. Strafella [Canada] ; Abbas F. Sadikot [Canada] ; Alain Dagher [Canada] | Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease |
| 000915 |
Aviva Abosch [Canada] ; Shitij Kapur [Canada] ; Anthony E. Lang [Canada] ; Doug Hussey [Canada] ; Elspeth Sime [Canada] ; Janis Miyasaki [Canada] ; Svlvain Houle [Canada] ; Andres M. Lozano [Canada] ; Philip Starr ; Giovanni Broggi ; Roy A. E. Bakay ; Nicholas Boulis ; Ali R. Rezai | Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Commentary |
| 000921 |
K. Fuxe [Suède] ; L. F. Agnati [Italie] ; K. Jacobsen [Canada] ; J. Hillion [États-Unis] ; M. Canals [Espagne] ; M. Torvinen [Suède] ; B. Tinner-Staines [Canada] ; W. Staines [Canada] ; D. Rosin [États-Unis] ; A. Terasmaa [Suède] ; P. Popoli [Italie] ; G. Leo [Italie] ; V. Vergoni [Italie] ; C. Lluis [Espagne] ; F. Ciruela [Espagne] ; R. Franco [Espagne] ; S. Ferre [États-Unis] | Receptor heteromerization in adenosine A2A receptor signaling: Relevance for striatal function and Parkinson's disease |
| 000925 |
Erwan Bezard [France] ; Christian E. Gross [France] ; Jonathan M. Brotchie [Canada] | Presymptomatic compensation in Parkinson's disease is not dopamine-mediated |
| 000966 |
Pierre J. Blanchet [États-Unis, Canada] ; Spiros Konitsiotis [États-Unis, Grèce] ; Hideki Mochizuki [États-Unis, Japon] ; Ryszard Pluta [États-Unis] ; Dwaine F. Emerich [États-Unis] ; Thomas N. Chase [États-Unis] ; M. Maral Mouradian [États-Unis] | Complications of a trophic xenotransplant approach in parkinsonian monkeys |
| 000979 |
C. Warren Olanow [États-Unis] ; Christopher G. Goetz [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; A. Jon Stoessl [Canada] ; Vesna Sossi [Canada] ; Mitchell F. Brin [États-Unis] ; Kathleen M. Shannon [États-Unis] ; G. Michael Nauert [États-Unis] ; Daniel P. Perl [États-Unis] ; James Godbold [États-Unis] ; Thomas B. Freeman [États-Unis] | A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's Disease |
| 000980 |
Robert Jr Laforce [Canada] | Revue des mécanismes d'apprentissage par lesquels le striatum participe à l'apprentissage implicite d'habiletés |
| 000991 |
Ivar Mendez [Canada] ; Alain Dagher ; Murray Hong ; Paula Gaudet ; Swarna Weerasinghe ; Vivian Mcalister ; David King ; Jacques Desrosiers ; Sultan Darvesh ; Tanya Acorn ; Harold Robertson | Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study: Report of three cases |
| 000A28 |
Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; Mariangela Zamburlini [Canada] ; Vesna Sossi [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Dopamine release in human ventral striatum and expectation of reward |
| 000A30 |
Janine F. Hay [Canada] ; Morris Moscovitch [Canada] ; Brian Levinc [Canada] | Dissociating habit and recollection: evidence from Parkinson's disease, amnesia and focal lesion patients |
| 000A31 |
Robert Jr Laforce [Canada] ; Julien Doyon [Canada] | Differential role for the striatum and cerebellum in response to novel movements using a motor learning paradigm |
| 000A37 |
Nicole Duchesne [Canada] ; Jean-Paul Soucy [Canada] ; Hélène Masson [Canada] ; Sylvain Chouinard [Canada] ; Marc-André Bedard [Canada] | Cognitive deficits and striatal dopaminergic denervation in Parkinson's disease: A single photon emission computed tomography study using 123Iodine-β-CIT in patients on and OFF levodopa |
| 000A43 |
Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Othman Ghribi [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Alteration of glutamate receptors in the striatum of dyskinetic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment |
| 000A52 |
Alain Dagher [Royaume-Uni, Canada] ; Adrian M. Owen [Royaume-Uni] ; Henning Boecker [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | The role of the striatum and hippocampus in planning : A PET activation study in Parkinson's disease |
| 000A61 |
Thomas N. Chase [États-Unis] ; Spiridon Konitsiotis [États-Unis] ; Justin D. Oh [États-Unis] | Striatal molecular mechanisms and motor dysfunction in Parkinson's disease |
| 000A87 |
M. Guttman [Canada] ; D. Stewart [Canada] ; D. Hussey [Canada] ; A. Wilson [Canada] ; S. Houle [Canada] ; S. Kish [Canada] | Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD |
| 000B07 |
Raul De La Fuente-Fernandez [Canada] ; Thomas J. Ruth [Canada] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Expectation and dopamine release: Mechanism of the placebo effect in Parkinson's disease |
| 000B10 |
Poornima K. Tekumalla [États-Unis] ; Frédéric Calon [Canada] ; Zia Rahman [États-Unis] ; Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Therese Di Paolo [Canada] ; Paul J. Bedard [Canada] ; Eric J. Nestler [États-Unis] | Elevated levels of ΔFosB and RGS9 in striatum in Parkinson's disease |
| 000B19 |
Robert Jr Laforce [Canada] ; Julien Doyon [Canada] | Distinct contribution of the striatum and cerebellum to motor learning |
| 000B20 |
Eric R. Marcotte [Canada] ; Anita Chugh [Canada] ; Cia Barlas [Canada] ; Ram K. Mishra [Canada] | Differential regulation of striatal G protein levels following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration in C57 BL/6 mice |
| 000B44 |
Y. L. Xue [République populaire de Chine] ; Z. F. Wang [République populaire de Chine] ; D. G. Zhong [République populaire de Chine] ; X. Cui [République populaire de Chine] ; X. J. Li [République populaire de Chine] ; X. J. Ma [République populaire de Chine] ; L. N. Wang [République populaire de Chine] ; K. Zhu [République populaire de Chine] ; A. M. Sun [Canada] | Xenotransplantation of microencapsulated bovine chromaffin cells into hemiparkinsonian monkeys |
| 000B56 |
I. Mendez [Canada] ; K. A. Baker [Canada] ; M. Hong [Canada] | Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease |
| 000B60 |
M. Goulet [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; S. Maltais [Canada] ; P. Falardeau [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada] | Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-Monkeys |
| 000B62 |
C. R. Honey [Canada] ; M. O. K. Obochi ; HAO SHEN ; P. Margaron ; S. Yip ; J. G. Levy | Reduced xenograft rejection in rat striatum after pretransplant photodynamic therapy of murine neural xenografts |
| 000B66 |
B. J. Snow [Canada] ; F. J. G. Vingerhoets [Canada] ; J. W. Langston [États-Unis] ; J. W. Tetrud [États-Unis] ; V. Sossi [Canada] ; D. B. Calne [Canada] | Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism |
| 000B86 |
K. A. Baker [Canada] ; M. Hong [Canada] ; D. Sadi [Canada] ; I. Mendez [Canada] | Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease |
| 000B88 |
C. S. Lee [Canada] ; A. Samii [Canada] ; V. Sossi [Canada] ; T. J. Ruth [Canada] ; M. Schulzer [Canada] ; J. E. Holden [États-Unis] ; J. Wudel [Canada] ; P. K. Pal [Canada] ; R. De La Fuente-Fernandez [Canada] ; D. B. Calne [Canada] ; A. J. Stoessl [Canada] | In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease |
| 000B94 |
C. S. Lee [Canada] ; M. A. Cenci [Suède] ; M. Schulzer [Canada] ; A. Björklund [Suède] | Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease |
| 000C27 |
M. Ichise [Canada] ; Y. J. Kim [Canada] ; J. R. Ballinger [Canada] ; D. Vines [Canada] ; S. S. Erami [Canada] ; F. Tanaka [Canada] ; A. E. Lang [Canada] | SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD |
| 000C52 |
A. Richter [Allemagne] ; U. Ebert [Allemagne] ; J. N. Nobrega [Canada] ; J. J. Vallbacka [Canada] ; M. Fedrowitz [Allemagne] ; W. Löscher [Allemagne] | Immunohistochemical and neurochemical studies on nigral and striatal functions in the circling (ci) rat, a genetic animal model with spontaneous rotational behavior |
| 000C54 |
M. Ichise [Canada] ; Y. J. Kim ; S. S. Erami ; J. R. Ballinger ; D. Vines ; F. Tanaka ; A. E. Lang | Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-β-CIT SPECT data |
| 000C56 |
T. Inoue [Canada, Japon] ; J. Tsui [Canada] ; N. Wong [Canada] ; SHIN YI WONG [Canada] ; F. Suzuki [Japon] ; YIN NAM KWOK [Canada] | Expression of glial cell line-derived neurotrophic factor and its mRNA in the nigrostriatal pathway following MPTP treatment |
| 000C59 |
T. A. Reader [Canada] ; K. M. Dewar [Canada] | Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum : implications for human Parkinson's disease |
| 000C62 |
R. Grondin [Canada] ; M. Goulet [Canada] ; M. Morissette [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada] | Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958 |
| 000D06 |
W. W. Martin [Canada] ; T. E. Roberts [Canada] ; F. Q. Ye [Canada] ; P. S. Allen [Canada] | Increased basal ganglia iron in striatonigral degeneration : In vivo estimation with magnetic resonance |
| 000D13 |
C. Apostolides [Canada] ; E. Sanford [Canada] ; M. Hong [Canada] ; I. Mendez [Canada] | Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells |
| 000D14 |
J. H. Kordower [États-Unis] ; T. B. Freeman [États-Unis] ; E.-Y. Chen [États-Unis] ; E. J. Mufson [États-Unis] ; P. R. Sanberg [États-Unis] ; R. A. Hauser [États-Unis] ; B. Snow [Canada] ; C. W. Olanow [États-Unis] | Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease |
| 000D22 |
S. J. Crocker [Canada] ; M. Morelli [Italie] ; N. Wigle [Canada] ; Y. Nakabeppu [Japon] ; G. S. Robertson [Canada] | D1-receptor-related priming is attenuated by antisense-meditated 'knockdown' of fosB expression |
| 000D24 |
C. J. Gibson [Canada] ; D. G. Munoz [Canada] | Chromogranin A inhibits dopamine release from rat striatal slices |
| 000D28 |
D. A. Loeffler [États-Unis] ; P. A. Lewitt [États-Unis] ; P. L. Juneau [États-Unis] ; D. M. Camp [États-Unis] ; A. J. Demaggio [États-Unis] ; P. Milbury [États-Unis] ; W. R. Matson [États-Unis] ; M. P. Rathbone [Canada] | Altered guanosine and guanine concentrations in rabbit striatum following increased dopamine turnover |
| 000D49 |
F. J. G. Vingerhoets [Canada] ; M. Schulzer [Canada] ; D. B. Calne [Canada] ; B. J. Snow [Canada] | Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? |
| 000D52 |
A. Parent [Canada] ; L.-N. Hazrati [Canada] ; A. Charara [Canada] | The striatopallidal fiber system in primates |
| 000D55 |
J. Doyon [Canada] ; D. Gaudreau [Canada] ; R. Jr Laforce [Canada] ; M. Castonguay [Canada] ; P. J. Bedard [Canada] ; F. Bedard [Canada] ; J.-P. Bouchard [Canada] | Role of the striatum, cerebellum, and frontal lobes in the learning of a visuomotor sequence |
| 000D58 |
I. Mendez [Canada] ; M. Hong [Canada] | Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: a tracer study using fluorogold and horseradish peroxidase |
| 000D75 |
A. E. Lang [Canada] ; A. Lozano [Canada] ; J. Duff [Canada] ; R. Tasker [Canada] ; J. Miyasaki ; N. Galvez-Jimenez ; W. Hutchison ; J. Dostrovsky | Medial pallidotomy in late-stage Parkinson's disease and striatonigral degeneration |
| 000D77 |
C. Thiffault [Canada] ; L. Lamarre-Theroux [Canada] ; R. Quirion [Canada] ; J. Poirier [Canada] | L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse |
| 000D84 |
N. Rajakumar [Canada] ; W. Rushlow [Canada] ; B. Rajakumar [Canada] ; C. C. G. Naus [Canada] ; A. J. Stoessl [Canada] ; B. A. Flumerfelt [Canada] | Effects of graft-derived dopaminergic innervation on the target neurons of patch and matrix compartments of the striatum |
| 000E22 |
J.-J. Soghomonian [Canada] ; S. Pedneault [Canada] ; P. J. Blanchet [Canada] ; M. Goulet [Canada] ; T. Di Paolo [Canada] ; P. J. Bedard [Canada] | L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys |
| 000E23 |
D. Boismenu [Canada] ; O. Mamer [Canada] ; L. Ste-Marie [Canada] ; L. Vachon [Canada] ; J. Montgomery [Canada] | In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors : Electrospray-MS analysis of intra-striatal microdialysates |
| 000E33 |
J. M. Wilson [Canada] ; A. I. Levey [États-Unis] ; A. Rajput [Canada] ; L. Ang [Canada] ; M. Guttman [Canada] ; K. Shannak [Canada] ; H. B. Niznik [Canada] ; O. Hornykiewicz [Canada, Autriche] ; C. Pifl [Autriche] ; S. J. Kish [Canada] | Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease |
| 000E42 |
B. J. Knowlton [États-Unis] ; J. A. Mangels [Canada, États-Unis] ; L. R. Squire [États-Unis] | A neostriatal habit learning system in humans |
| 000E48 |
J.-A. St-Pierre [Canada] ; P. J. Bedard | Systemic administration of the NMDA receptor antagonist MK-801 potentiates circling induced by intrastriatal microinjection of dopamine |
| 000E49 |
XIAO-HUI ZHONG [Canada] ; J. W. Haycock ; K. Shannak [Canada] ; Y. Robitaille ; J. Fratkin ; A. H. Koeppen ; O. Hornykiewicz [Canada] ; S. J. Kish [Canada] | Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy |
| 000E58 |
F. Calon [Canada] ; M. Goulet [Canada] ; P. J. Blanchet ; J. C. Martel [Canada] ; M. F. Piercey ; P. J. Bedard ; T. Di Paolo [Canada] | Levodopa or D2 agonist induced dyskinesia in MPTP monkeys : correlation with changes in dopamine and GABAA receptors in the striatopallidal complex |
| 000E60 |
P. J. Blanchet ; B. Gomez-Mancilla [Canada] ; T. Di Paolo ; P. J. Bedard | Is striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia ? |
| 000E83 |
M. Filion [Canada] ; L. Tremblay ; M. Matsumura ; H. Richard | Focalisation dynamique de la convergence informationnelle dans les noyaux gris centraux |
| 000E88 |
E. Scarr [Canada] ; D. M. Wingerchuk ; A. V. Juorio ; I. A. Paterson | The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions |
| 000E93 |
M.-C. Asselin [Canada] ; J.-J. Soghomonian ; P.-Y. Côte ; A. Parent | Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys |
| 000F22 |
A. Gjedde [Canada] ; G. C. Leger ; P. Cumming ; Y. Yasuhara ; A. C. Evans ; M. Guttman ; H. Kuwabara | Striatal L-DOPA decarboxylase activity in Parkinson's disease in vivo : implications for the regulation of dopamine synthesis |
| 000F46 |
B. D. Pate [Canada] ; T. Kawamata ; T. Yamada ; E. G. Mcgeer [Canada] ; K. A. Hewitt [Canada] ; B. J. Snow [Canada] ; T. J. Ruth [Canada] ; D. B. Calne [Canada] | Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices |
| 000F54 |
K. Mizukawa [Canada] ; E. G. Mcgeer ; P. L. Mcgeer | Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, alzheimer disease, and neurologically normal controls |
| 000F59 |
L. Rioux [Canada] ; C. Gagnon ; D. P. Gaudin [Canada] ; T. Di Paolo ; P. J. Bedard [Canada] | A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections of L-dopa in 6-OHDA rats. Correlation with D1 and D2 receptors |
| 000F79 |
A. Tabatabaei [Canada] ; T. L. Perry ; S. Hansen ; C. Krieger | Partial protective effect of MK-4801 on MPTP-induced reduction of striatal dopamine in mice |
| 000F97 |
M. L. Paul [Canada] ; A. M. Graybiel ; J.-C. David ; H. A. Robertson [Canada] | D1-like and D2-like dopamine receptors synergistically actitave rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease |
| 001007 |
S. J. Kish [Canada] ; K. Shannak ; A. Rajput ; J. H. N. Deck ; O. Hornykiewicz | Aging produces a specific pattern of striatal dopamine loss : implications for the etiology of idopathic Parkinson's disease |
| 001010 |
M. Cordes [Canada] ; B. J. Snow ; H. Takahashi ; P. Schofield ; S. Cooper ; V. Sossi ; S. Morrison ; D. B. Calne | L-18F-DOPA-PET bei Parkinson-Plus-Syndromen zum Nachweis einer gestörten präsynaptischen dopaminergen Funktion |
| 001051 |
B. J. Snow ; R. F. Peppard ; M. Guttman ; J. Okada ; W. Martin ; J. Steele ; A. Eisen ; G. Carr ; B. Schoenberg ; D. Calne | Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in lytico-bodig : the amyotrophic lateral sclerosis-Parkinsonism-dementia complex of guam |
| 001085 |
L. Tremblay ; M. Filion ; P. J. Bedard | Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism |
| 001093 |
G. S. Robertson ; D. G. Herrera ; M. Dragunow ; H. A. Robertson | L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra |
| 001097 |
C. Harnois ; G. Marcotte ; T. Di Paolo | Different sensitivities to MPTP toxicity in primate nigrostriatal and retinal dopaminergic systems: electrophysiological and biochemical evidence |
| 001108 |
T. L. Perry ; K. Jones ; S. Hansen | Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice |
| 001112 |
M. Pisa | Regional specialization of motor functions in the rat striatum: implications for the treatment of parkinsonism |
| 001131 |
T. L. Perry ; K. Jones ; S. Hansen ; R. A. Wall | 2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease |
| 001132 |
J. H. Thakar ; M. N. Hassan ; J. D. Grimes | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), its metabolite cyperquat (MPP+) and energy transduction in mitochondria from rat striatum and liver |
| 001139 |
A. A. F. Sima ; G. Hoag ; B. Rozdilsky | Shy-Drager syndrome: the transitional variant |
| 001146 |
A. E. Lang | Manipulating the dopaminergic system in Parkinson's disease |
| 001175 |
J. Kish ; A. Rajput ; J. Gilbert ; B. Rozdilsky ; L.-J. Chang ; K. Shannak ; O. Hornykiewicz | Elevated γ-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss |
